Topics

Artificial intelligence programs reviewed tens of thousands of human drug studies, found a pattern tied to success, and proposed a lung cancer design later taken up by a manufacturer.

Rentosertib, built with generative AI for scarred lungs, starts a year-long study after protein clocks suggested treated patients looked biologically younger.

Six independent protein-based aging clocks moved younger in forty-two patients with idiopathic pulmonary fibrosis, with the strongest signal at four weeks on a mid-range dose.

A polymer nanogel crossed into the brain, lowered one protein in support cells, and produced working neurons plus better memory in mice.

Scientists used AI to generate 16 viable viruses not found in nature, marking a first that experts say demands urgent safeguards against dual-use risks.

A custom treatment built from each patient's tumor mutations, given with an existing immunotherapy, met its main goals in a large late-stage study and relies on computational ranking of targets.

University of Chicago scientists rewired Bifidobacterium longum to pump SumIL-2 inside tumors, suppressing pancreatic cancer growth in mouse models.